Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".
作者信息
Kwo Paul Y
机构信息
Division of Gastroenterology and Hepatology, Stanford University Medical School, Stanford, CA, USA.
出版信息
Clin Mol Hepatol. 2024 Oct;30(4):714-717. doi: 10.3350/cmh.2024.0425. Epub 2024 Jun 11.
Abstract
摘要
相似文献
1
Metformin and statins and their role in reducing hepatocellular carcinoma risk: Randomized trials are needed: Editorial on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".
Clin Mol Hepatol. 2024 Oct;30(4):714-717. doi: 10.3350/cmh.2024.0425. Epub 2024 Jun 11.
2
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Clin Mol Hepatol. 2024 Jul;30(3):468-486. doi: 10.3350/cmh.2024.0038. Epub 2024 Apr 19.
3
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol. 2023 Feb;78(2):281-292. doi: 10.1016/j.jhep.2022.09.019. Epub 2022 Oct 5.
4
Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin.
World J Hepatol. 2015 May 18;7(8):1105-11. doi: 10.4254/wjh.v7.i8.1105.
5
Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
Viruses. 2023 Dec 17;15(12):2451. doi: 10.3390/v15122451.
6
Reply to correspondence on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".
Clin Mol Hepatol. 2024 Oct;30(4):1050-1052. doi: 10.3350/cmh.2024.0546. Epub 2024 Jul 12.
7
Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.
Cancer Med. 2023 Oct;12(19):19548-19559. doi: 10.1002/cam4.6569. Epub 2023 Sep 22.
8
Metformin as adjuvant treatment in hepatitis C virus infections and associated complications.
Am J Med Sci. 2024 Aug;368(2):90-98. doi: 10.1016/j.amjms.2024.04.019. Epub 2024 May 1.
9
Statins in Hepatitis B or C Patients Is Associated With Reduced Hepatocellular Carcinoma Risk: A Systematic Review and Meta-Analysis.
Turk J Gastroenterol. 2022 Feb;33(2):136-144. doi: 10.5152/tjg.2020.19656.
10
Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Aliment Pharmacol Ther. 2023 Mar;57(6):600-609. doi: 10.1111/apt.17371. Epub 2023 Jan 10.
引用本文的文献
1
Metformin in Antiviral Therapy: Evidence and Perspectives.
Viruses. 2024 Dec 18;16(12):1938. doi: 10.3390/v16121938.
2
Reply to correspondence on "Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy".
Clin Mol Hepatol. 2024 Oct;30(4):1050-1052. doi: 10.3350/cmh.2024.0546. Epub 2024 Jul 12.
本文引用的文献
1
Association of GLP-1 Receptor Agonists and Hepatocellular Carcinoma Incidence and Hepatic Decompensation in Patients With Type 2 Diabetes.
Gastroenterology. 2024 Sep;167(4):689-703. doi: 10.1053/j.gastro.2024.04.029. Epub 2024 Apr 29.
2
Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy.
Clin Mol Hepatol. 2024 Jul;30(3):468-486. doi: 10.3350/cmh.2024.0038. Epub 2024 Apr 19.
3
Management of type 2 diabetes in patients with compensated liver cirrhosis: Short of evidence, plenty of potential.
Diabetes Metab Syndr. 2024 Jan;18(1):102935. doi: 10.1016/j.dsx.2023.102935. Epub 2023 Dec 28.
4
Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.
J Hepatol. 2023 Feb;78(2):281-292. doi: 10.1016/j.jhep.2022.09.019. Epub 2022 Oct 5.
5
Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?
Clin Mol Hepatol. 2022 Jul;28(3):380-395. doi: 10.3350/cmh.2021.0366. Epub 2022 Jan 13.
6
Efficacy and Safety of Statin for Hepatocellular Carcinoma Prevention Among Chronic Liver Disease Patients: A Systematic Review and Meta-analysis.
J Clin Gastroenterol. 2021 Aug 1;55(7):615-623. doi: 10.1097/MCG.0000000000001478.
7
Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
Ann Intern Med. 2019 Sep 3;171(5):318-327. doi: 10.7326/M18-2753. Epub 2019 Aug 20.
8
Global Elimination of Chronic Hepatitis.
N Engl J Med. 2019 May 23;380(21):2041-2050. doi: 10.1056/NEJMra1810477.
9
Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
World J Gastroenterol. 2018 Dec 21;24(47):5297-5311. doi: 10.3748/wjg.v24.i47.5297.
10
What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.
Gastroenterology. 2019 Jan;156(2):297-310. doi: 10.1053/j.gastro.2018.10.048. Epub 2018 Nov 2.
Zotero 插件